Abstract:Understanding the metabolic fate of a xenobiotic substance can help inform its potential health risks and allow for the identification of signature metabolites associated with exposure. The need to characterize metabolites of poorly studied or novel substances has shifted exposure studies towards non-targeted analysis (NTA), which often aims to profile many compounds within a sample using high-resolution liquid-chromatography mass-spectrometry (LCMS). Here we evaluate the suitability of suspect screening analysis (SSA) liquid-chromatography mass-spectrometry to inform xenobiotic chemical metabolism. Given a lack of knowledge of true metabolites for most chemicals, predictive tools were used to generate potential metabolites as suspect screening lists to guide the identification of selected xenobiotic substances and their associated metabolites. Thirty-three substances were selected to represent a diverse array of pharmaceutical, agrochemical, and industrial chemicals from Environmental Protection Agency’s ToxCast chemical library. The compounds were incubated in a metabolically-active in vitro assay using primary hepatocytes and the resulting supernatant and lysate fractions were analyzed with high-resolution LCMS. Metabolites were simulated for each compound structure using software and then combined to serve as the suspect screening list. The exact masses of the predicted metabolites were then used to select LCMS features for fragmentation via tandem mass spectrometry (MS/MS). Of the starting chemicals, 12 were measured in at least one sample in either positive or negative ion mode and a subset of these were used to develop the analysis workflow. We implemented a screening level workflow for background subtraction and the incorporation of time-varying kinetics into the identification of likely metabolites. We used haloperidol as a case study to perform an in-depth analysis, which resulted in identifying five known metabolites and five molecular features that represent potential novel metabolites, two of which were assigned discrete structures based on in silico predictions. This workflow was applied to five additional test chemicals, and 15 molecular features were selected as either reported metabolites, predicted metabolites, or potential metabolites without a structural assignment. This study demonstrates that in some–but not all–cases, suspect screening analysis methods provide a means to rapidly identify and characterize metabolites of xenobiotic chemicals.

Identification of Xenobiotic Biotransformation Products Using Mass Spectrometry-Based Metabolomics Integrated with a Structural Elucidation Strategy by Assembling Fragment Signatures

Application of Mass Spectrometry for Metabolite Identification

Analytical strategies for identifying drug metabolites

Structure Annotation of All Mass Spectra in Untargeted Metabolomics

Untargeted screening of unknown xenobiotics and potential toxins in plasma of poisoned patients using high-resolution mass spectrometry: Generation of xenobiotic fingerprint using background subtraction

Identifying xenobiotic metabolites with in silico prediction tools and LCMS suspect screening analysis

Retention Time and Optimal Collision Energy Advance Structural Annotation Relied on LC-MS/MS: an Application in Metabolite Identification of an Antidementia Agent Namely Echinacoside

An approach to identifying sequential metabolites of a typical phenylethanoid glycoside, echinacoside, based on liquid chromatography-ion trap-time of flight mass spectrometry analysis.

A systemic workflow for profiling metabolome and lipidome in tissue.

Strategy Strengthens Structural Identification Through Hyphenating Full Collision Energy Ramp-Ms2 and Full Exciting Energy Ramp-Ms3 Spectra: an Application for Metabolites Identification of Rosmarinic Acid.

A multi-dimensional liquid chromatography/high-resolution mass spectrometry approach combined with computational data processing for the comprehensive characterization of the multicomponents from Cuscuta chinensis

A strategy for metabolite identification using triple-quadrupole mass spectrometry with enhanced resolution and accurate mass capability.

Molecular structure discovery for untargeted metabolomics using biotransformation rules and global molecular networking

Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.

The Profiling of the Metabolites of Hirsutine in Rat by Ultra-High Performance Liquid Chromatography Coupled with Linear Ion Trap Orbitrap Mass Spectrometry: an Improved Strategy for the Systematic Screening and Identification of Metabolites in Multi-Samples in Vivo

Liquid Chromatography–three-Dimensional Mass Spectrometry Enables Confirmative Structural Annotation of Cistanoside F Metabolites in Rat

Metabolite profiling and characterization for medicinal herbal remedies.

Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome

Integrated Work-Flow for Quantitative Metabolome Profiling of Plants, Peucedani Radix As a Case.

Chemical Structure Elucidation from Mass Spectrometry by Matching Substructures

Application of Electro-Activated Dissociation Fragmentation Technique to Identifying Glucuronidation and Oxidative Metabolism Sites of Vepdegestrant by Liquid Chromatography-High Resolution Mass Spectrometry